Clinical study evaluating the effect of bevacizumab on the severity of zoledronic acid-related osteonecrosis of the jaw in cancer patients. [electronic resource]
Producer: 20140831Description: 103-7 p. digitalISSN:- 1873-2763
- Antibodies, Monoclonal, Humanized -- therapeutic use
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Bevacizumab
- Bisphosphonate-Associated Osteonecrosis of the Jaw -- drug therapy
- Diphosphonates -- adverse effects
- Female
- Humans
- Imidazoles -- adverse effects
- Kaplan-Meier Estimate
- Male
- Middle Aged
- Neoplasms -- drug therapy
- Risk Factors
- Treatment Outcome
- Zoledronic Acid
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.